PressDigest

Valeant and Shire plot Salix takeover

Salix Pharmaceuticals, the US drugmaker with a market capitalisation of almost $10bn, is in talks with acquisitive Canadian rival Valeant Pharmaceuticals over potentially selling itself, The New York Times gathers.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump